GlassScriptPhysician profile
James R Bruns
NPI 1942411236
$4,018.04
in general payments reported to CMS, 2019-2025
20 companies · $635 in 2025
The $635 reported for 2025 was more than what a typical Pain Medicine (Anesthesiology) provider received nationally (typical 2025 total: $458).
See the full distribution for Pain Medicine (Anesthesiology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $325 · 2020: $91.69 · 2021: $118 · 2022: $559 · 2023: $1,285 · 2024: $1,005 · 2025: $635.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,667 · Travel and Lodging: $258.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,666.85 |
| Travel and Lodging | $257.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,604.10 | 2019-2025 | Wavewriter Alpha Prime 16, Superion Indirect Decompression System, Patient Trial Kit |
| Abbvie INC. | $529.08 | 2021-2025 | Ubrelvy, Qulipta |
| Abbott Laboratories | $517.77 | 2022-2025 | Eterna, Proclaim |
| Collegium Pharmaceutical, INC. | $443.10 | 2023-2025 | Belbuca, Xtampza |
| Relievant Medsystems, INC. | $184.58 | 2023 | Intracept |
| Spr Therapeutics, INC | $149.21 | 2019-2024 | Sprint Pns System |
| Medtronic, INC. | $144.60 | 2023-2025 | Intellis Adaptivestim, Inceptiv |
| Globus Medical, INC. | $78.10 | 2025 | Senza |
| Biodelivery Sciences International, INC. | $55.98 | 2020-2021 | |
| Novartis Pharmaceuticals Corporation | $47.33 | 2020 | |
| Nevro Corp. | $44.99 | 2019-2024 | Senza |
| Biotronik Nro, INC. | $38.05 | 2025 | Prospera |
| Supernus Pharmaceuticals, INC. | $31.34 | 2019-2021 | |
| Saluda Medical Americas, INC. | $30.32 | 2025 | Evoke |
| Convatec INC. | $25.75 | 2025 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic USA, INC. | $22.51 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $22.28 | 2024 | Relistor |
| Curonix LLC | $20.87 | 2024 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Ethicon US, LLC | $16.46 | 2023 | Dermabond Prineo, Stratafix |
| Amgen INC. | $11.62 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Bruns listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.